PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33114555-0	2020	Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3.	olaparib	0-8	aldo-keto reductase family 1 member C3	Homo sapiens	81-87	
33114555-3	2020	Incubation experiments with the most active recombinant CREs showed that olaparib is a potent inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme.	olaparib	73-81	aldo-keto reductase family 1 member C3	Homo sapiens	111-134	
33114555-3	2020	Incubation experiments with the most active recombinant CREs showed that olaparib is a potent inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme.	olaparib	73-81	aldo-keto reductase family 1 member C3	Homo sapiens	136-142	
33114555-4	2020	Subsequent inhibitory assays in the AKR1C3-overexpressing cellular model transfected human colorectal carcinoma HCT116 cells, demonstrating that olaparib significantly inhibits AKR1C3 at the intracellular level.	olaparib	145-153	aldo-keto reductase family 1 member C3	Homo sapiens	36-42	
33114555-4	2020	Subsequent inhibitory assays in the AKR1C3-overexpressing cellular model transfected human colorectal carcinoma HCT116 cells, demonstrating that olaparib significantly inhibits AKR1C3 at the intracellular level.	olaparib	145-153	aldo-keto reductase family 1 member C3	Homo sapiens	177-183